Market cap
$6,102 Mln
Revenue (TTM)
$1,222 Mln
P/E Ratio
38.5
P/B Ratio
3.3
Div. Yield
0 %
Quality Score
/10
Growth Score
/10
Valuation Score
/10
Momentum Score
/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
0.1 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
18.7
-
Debt to Equity
--
-
Book Value
$--
-
EPS
$--
-
Face value
--
-
Shares outstanding
49,709,718
5 Years Aggregate
CFO
€537.88 Mln
EBITDA
€931.46 Mln
Net Profit
€540.52 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Stevanato Group SpA (STVN)
| 5.8 | 7.5 | 17.8 | -5.0 | -13.1 | -3.3 | -- |
|
BSE Sensex
| -8.8 | 0.6 | 1.8 | -4.4 | 6.0 | 6.6 | 10.8 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2023
|
2022
|
|---|---|---|---|
|
Stevanato Group SpA (STVN)
| -7.7 | 51.9 | -20.0 |
|
S&P Small-Cap 600
| 4.0 | 13.9 | -17.4 |
|
BSE Sensex
| 9.1 | 18.7 | 4.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Shareholding Pattern
View DetailsAbout Stevanato Group SpA (STVN)
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific.... It operates through two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. The company offers drug containment solutions comprising pre-fillable syringes, cartridges, vials, and ampoules; in-vitro diagnostic solutions; drug delivery systems, including pen injectors, auto-injectors, and wearable injectors; diagnostic laboratory consumables; analytical and regulatory support services; medical devices; pharmaceutical visual inspection machines; assembling and packaging machines; glass converting machines; and after-sales services, such as line optimization and line conversions, training, logistics, spare parts and maintenance services. It also provides contract development and manufacturing services for customer-owned drug delivery devices. The company serves pharmaceutical, biotechnology, diagnostics, and life sciences companies; and drug products, glass packaging, and fill and finish contract manufacturers. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L. Read more
-
Executive Chairman
Mr. Franco Stevanato
-
CEO & Executive Chairman
Mr. Franco Stevanato
-
Headquarters
Piombino Dese, PD
-
Website
FAQs for Stevanato Group SpA (STVN)
What is the current share price of Stevanato Group SpA (STVN) Today?
The share price of Stevanato Group SpA (STVN) is $21.28 (NYSE) as of 28-Aug-2026 13:44 EDT. Stevanato Group SpA (STVN) has given a return of -13.06% in the last 3 years.
What is the current PB & PE ratio of Stevanato Group SpA (STVN)?
The P/E ratio of Stevanato Group SpA (STVN) is 38.53 times as on 21-Aug-2026.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
40.90 |
3.70 |
2024 |
50.49 |
4.23 |
2023 |
49.75 |
6.40 |
2022 |
33.30 |
4.78 |
2021 |
44.24 |
7.06 |
What is the 52 Week High and Low of Stevanato Group SpA (STVN)?
The 52-week high and low of Stevanato Group SpA (STVN) are Rs 28.00 and Rs 12.89 as of 29-Aug-2026.
What is the market cap of Stevanato Group SpA (STVN)?
Stevanato Group SpA (STVN) has a market capitalisation of $ 6,102 Mln as on 21-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Stevanato Group SpA (STVN)?
Before investing in Stevanato Group SpA (STVN), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.